These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 21537170
21. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization. Barker PM, McCannon CJ, Mehta N, Green C, Youngleson MS, Yarrow J, Bennett B, Berwick DM. J Infect Dis; 2007 Dec 01; 196 Suppl 3():S457-63. PubMed ID: 18181694 [Abstract] [Full Text] [Related]
23. [Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)]. de Loenzien M. Sante; 2009 Dec 01; 19(3):141-8. PubMed ID: 20185390 [Abstract] [Full Text] [Related]
24. Inequalities in health: access to treatment for HIV/AIDS. Giuliano M, Vella S. Ann Ist Super Sanita; 2007 Dec 01; 43(4):313-6. PubMed ID: 18209264 [Abstract] [Full Text] [Related]
26. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries. Orsi F, d'almeida C. Curr Opin HIV AIDS; 2010 May 01; 5(3):237-41. PubMed ID: 20539080 [Abstract] [Full Text] [Related]
27. Family planning operations research in Africa: reviewing a decade of experience. Wawer MJ, McNamara R, McGinn T, Lauro D. Stud Fam Plann; 1991 May 01; 22(5):279-93. PubMed ID: 1759274 [Abstract] [Full Text] [Related]
30. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. Hanefeld J. AIDS Care; 2010 May 01; 22 Suppl 1():93-102. PubMed ID: 20680864 [Abstract] [Full Text] [Related]
31. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world. Bennett DE. Curr Opin Infect Dis; 2006 Dec 01; 19(6):607-14. PubMed ID: 17075338 [Abstract] [Full Text] [Related]
35. The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand. Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, Suebsaeng L, Lo YR. Southeast Asian J Trop Med Public Health; 2006 Jul 01; 37(4):704-15. PubMed ID: 17121296 [Abstract] [Full Text] [Related]
36. Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116). Marcellin F, Protopopescu C, Abé C, Boyer S, Blanche J, Ongolo-Zogo P, Koulla-Shiro S, Moatti JP, Carrieri MP, Spire B, EVAL Study Group. AIDS Care; 2010 Apr 01; 22(4):441-51. PubMed ID: 20140791 [Abstract] [Full Text] [Related]
37. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Nachega JB, Mills EJ, Schechter M. Curr Opin HIV AIDS; 2010 Jan 01; 5(1):70-7. PubMed ID: 20046150 [Abstract] [Full Text] [Related]
38. Influence of antiretroviral therapy on liver disease. Kovari H, Weber R. Curr Opin HIV AIDS; 2011 Jul 01; 6(4):272-7. PubMed ID: 21508839 [Abstract] [Full Text] [Related]
39. Lessons learned from use of highly active antiretroviral therapy in Africa. Akileswaran C, Lurie MN, Flanigan TP, Mayer KH. Clin Infect Dis; 2005 Aug 01; 41(3):376-85. PubMed ID: 16007536 [Abstract] [Full Text] [Related]